PARP1 and neoplasm: This observation aligns with the enhancement of TMZ effect by PEG~TLZ in SMARCB1-deficient MRT xenografts, where DDR mechanisms are disrupted by PARP1 inhibition and alkylating DNA damage, leading to tumor cell death and combination drug efficacy.